Blog Posts
Explore timely perspectives from WCG’s clinical trial operations and scientific leaders.
WCG Clinical | Insights
Key Takeaways From FDA’s New Draft Guidance, “Studying Multiple Versions of a Cellular or Gene Therapy Product in an Early-Phase Clinical Trial”
Blog Posts
WCG Clinical | Insights
Does the IRB need to approve doctor-to-doctor letters?
Blog Posts
WCG Clinical | Insights
What are the IRB review requirements for human factors/usability testing?
Blog Posts
WCG Clinical | Insights
Five Tips for Improving Your Site’s Study Start-Up Timelines
Blog Posts
WCG Clinical | Insights
Choosing Between Provisioned, BYOD, and Hybrid Models for ePRO: Which Is Right for Your Clinical Trial?
Blog Posts
WCG Clinical | Insights
A Successful DMC Requires a Productive, Early Organizational Meeting
Blog Posts
WCG Clinical | Insights
Five Tips for Creating & Negotiating the Best Clinical Trial Budget for Your Site
Blog Posts
WCG Clinical | Insights
Emerging Challenges in Oncology Trials: Enrollment, Protocol Deviations, and Growing Data
Blog Posts
WCG Clinical | Insights
Can a physician submit a single humanitarian use device (HUD) submission to the IRB?
Blog Posts
WCG Clinical | Insights